Published in Horm Res on January 01, 2001
Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter. Pflugers Arch (2003) 1.05
FGF23 and syndromes of abnormal renal phosphate handling. Adv Exp Med Biol (2012) 0.92
New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis. Mamm Genome (2012) 0.88
FGF23 and Phosphate Wasting Disorders. Bone Res (2013) 0.81
FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. J Bone Miner Metab (2011) 0.79
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab (2001) 3.55
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int (2001) 3.44
An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature (1994) 2.57
Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature (1994) 2.49
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry (2001) 2.27
Clinical and molecular delineation of the 17q21.31 microdeletion syndrome. J Med Genet (2008) 2.09
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet (2001) 2.06
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64
Identification of coexpressed gene clusters in a comparative analysis of transcriptome and proteome in mouse tissues. Proc Natl Acad Sci U S A (2005) 1.28
Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia (2011) 1.20
Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets. Genome Res (1997) 1.19
Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. Neurology (2006) 1.06
A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures. Neurology (2009) 1.05
Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab (2001) 1.02
A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol (1997) 1.02
Cloning and gene structure of the rod cGMP phosphodiesterase delta subunit gene (PDED) in man and mouse. Eur J Hum Genet (1998) 0.98
Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Hum Mol Genet (1998) 0.88
A PHEX gene mutation is responsible for adult-onset vitamin D-resistant hypophosphatemic osteomalacia: evidence that the disorder is not a distinct entity from X-linked hypophosphatemic rickets. J Clin Endocrinol Metab (1998) 0.84
Analysis of an interstitial deletion in a patient with Kallmann syndrome, X-linked ichthyosis and mental retardation. Clin Genet (1998) 0.80
X-linked congenital adrenal hypoplasia: new mutations and long-term follow-up in three patients. Clin Endocrinol (Oxf) (2000) 0.79
A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis. Neurogenetics (2008) 0.79
Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life. J Clin Endocrinol Metab (1987) 0.78
Allelic imbalance at intragenic markers of Tbx18 is a hallmark of murine osteosarcoma. Carcinogenesis (2003) 0.78
Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes. Neurogenetics (2006) 0.78
Somatic mosaicism in a Cornelia de Lange syndrome patient with NIPBL mutation identified by different next generation sequencing approaches. Clin Genet (2014) 0.77
Combination of high-performance liquid chromatography and radioimmunoassay for the measurement of urodilatin and alpha-hANP in the urine of healthy males. Life Sci (1991) 0.77
Platelet receptors for atrial natriuretic peptide in man. Life Sci (1987) 0.77
Remarkable long-term prognosis and excellent growth in kidney-transplant children under cyclosporine monotherapy. Transplant Proc (1991) 0.77
Effects of a bolus dose of atrial natriuretic factor in young and elderly volunteers. Eur J Clin Invest (1989) 0.76
Plasma atrial natriuretic peptide levels in children with cardiac diseases: correlation with cGMP levels and haemodynamic parameters. Horm Res (1987) 0.75
[29-year-old patient with gynecomastia and small testis]. Internist (Berl) (1999) 0.75
[OP.LB01.12] CACNA1H MUTATIONS ARE ASSOCIATED WITH YOUNG ONSET AND FAMILIAL FORMS OF PRIMARY ALDOSTERONISM. J Hypertens (2016) 0.75
Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels. Z Kardiol (1988) 0.75
Isolation and fine mapping of (CA)n repeats from the Xp11.23 and Xp11.4 region. Hum Mol Genet (1994) 0.75